Trupanion COO John Gallagher sells $191,600 in stock

Trupanion COO John R. Gallagher sold 4,000 shares of TRUP at $47.90 on May 29, 2025, for a total of $191,600, retaining 26,966 shares. This follows Trupanion's Q1 2025 results that exceeded expectations with an EPS of -$0.03 and revenue of $342 million, a 12% year-over-year increase; the company's subsidiary, American Pet Insurance Company, also received approval to pay an extraordinary dividend of $26 million to its parent company. Trupanion has provided full-year 2025 revenue guidance of $1.390 to $1.425 billion, indicating a 14% growth at the midpoint.

Analysis

Trupanion, Inc. (NASDAQ:TRUP) Chief Operating Officer John R. Gallagher executed a sale of 4,000 common shares at $47.90 each on May 29, 2025, totaling $191,600, reducing his holdings to 26,966 shares; this insider transaction follows a period where Trupanion's stock delivered a 56% return over the past year. The company recently reported strong Q1 2025 financial results, with earnings per share of -$0.03 outperforming the forecasted -$0.05, and revenue of $342 million surpassing the projected $337.82 million, marking a 12% year-over-year increase. Furthermore, operating cash flow demonstrated significant improvement, rising to $16 million from $2.4 million in the previous year, and Trupanion’s subsidiary, American Pet Insurance Company, received approval to pay an extraordinary dividend of $26 million to the parent company, a move indicative of its financial health. Trupanion has also issued positive full-year 2025 revenue guidance of $1.390 to $1.425 billion, suggesting 14% growth at the midpoint, and Q2 2025 revenue guidance between $344 million and $350 million, underscoring its commitment to growth and financial stability. While InvestingPro assigns a "GOOD" financial health score and analyst price targets range from $41 to $60, the stock exhibits notable volatility.

Key Decisions for Investors

• Investors should carefully evaluate the COO's share sale in the context of his remaining significant holdings and the stock's substantial prior appreciation, alongside the company's robust Q1 2025 performance and positive forward-looking guidance.
• Given Trupanion's reported 12% year-over-year revenue growth, improved operating cash flow to $16 million, and projected 14% full-year revenue growth, positions should be managed with an awareness of the stock's notable volatility, even with analyst price targets between $41 and $60.
• The $26 million extraordinary dividend from its subsidiary bolsters confidence in financial health, but continued monitoring of revenue growth against guidance and operating efficiencies is advised to ensure sustained momentum.